185 related articles for article (PubMed ID: 3863691)
1. Values of CA 19-9 in the serum, pure pancreatic juice, and aspirated pancreatic material in the diagnosis of malignant pancreatic tumor.
Tatsuta M; Yamamura H; Iishi H; Ichii M; Noguchi S; Yamamoto R; Okuda S
Cancer; 1985 Dec; 56(11):2669-73. PubMed ID: 3863691
[TBL] [Abstract][Full Text] [Related]
2. Cytologic examination and CEA measurement in aspirated pancreatic material collected by percutaneous fine-needle aspiration biopsy under ultrasonic guidance for the diagnosis of pancreatic carcinoma.
Tatsuta M; Yamamoto R; Yamamura H; Okuda S; Tamura H
Cancer; 1983 Aug; 52(4):693-8. PubMed ID: 6861105
[TBL] [Abstract][Full Text] [Related]
3. Significance of carcinoembryonic antigen levels and cytology of pure pancreatic juice in diagnosis of pancreatic cancer.
Tatsuta M; Yamamura H; Yamamoto R; Okano Y; Morii T; Okuda S; Tamura H
Cancer; 1983 Nov; 52(10):1880-5. PubMed ID: 6627206
[TBL] [Abstract][Full Text] [Related]
4. Estimation of carbohydrate antigen (CA) 19-9 levels in pure pancreatic juice of patients with pancreatic cancer.
Nishida K; Tasaki N; Miyagawa H; Yoshikawa T; Kondo M
Am J Gastroenterol; 1988 Feb; 83(2):126-9. PubMed ID: 3422536
[TBL] [Abstract][Full Text] [Related]
5. Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis.
Malesci A; Tommasini MA; Bonato C; Bocchia P; Bersani M; Zerbi A; Beretta E; Di Carlo V
Gastroenterology; 1987 Jan; 92(1):60-7. PubMed ID: 3465666
[TBL] [Abstract][Full Text] [Related]
6. Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas.
Tatsuta M; Iishi H; Ichii M; Noguchi S; Yamamoto R; Yamamura H; Okuda S
Cancer; 1986 May; 57(9):1836-9. PubMed ID: 2420441
[TBL] [Abstract][Full Text] [Related]
7. Cytologic examination of pure pancreatic juice in the diagnosis of pancreatic carcinoma. The endoscopic retrograde intraductal catheter aspiration cytologic technique.
Nakaizumi A; Tatsuta M; Uehara H; Yamamoto R; Takenaka A; Kishigami Y; Takemura K; Kitamura T; Okuda S
Cancer; 1992 Dec; 70(11):2610-4. PubMed ID: 1423189
[TBL] [Abstract][Full Text] [Related]
8. Tumour antigens CA 195 and CA 19-9 in pancreatic juice and serum for the diagnosis of pancreatic carcinoma.
Hyöty M; Hyöty H; Aaran RK; Airo I; Nordback I
Eur J Surg; 1992 Mar; 158(3):173-9. PubMed ID: 1356458
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody defines CA 19-9 in pancreatic juices and sera.
Schmiegel WH; Kreiker C; Eberl W; Arndt R; Classen M; Greten H; Jessen K; Kalthoff H; Soehendra N; Thiele HG
Gut; 1985 May; 26(5):456-60. PubMed ID: 3858206
[TBL] [Abstract][Full Text] [Related]
10. Carcinoembryonic antigen (CEA) activity in pancreatic juice of patients with pancreatic carcinoma and pancreatitis.
Sharma MP; Gregg JA; Loewenstein MS; McCabe RP; Zamcheck N
Cancer; 1976 Dec; 38(6):2457-61. PubMed ID: 1000475
[TBL] [Abstract][Full Text] [Related]
11. Significance of adenocarcinoma-associated antigen YH206 levels in the pancreatic juice.
Imai K; Ban T; Endo T; Hinoda Y; Sugiyama T; Hirane T; Yabana T; Hirata K; Wada T; Yachi A
Gastroenterol Jpn; 1990 Feb; 25(1):112-6. PubMed ID: 2407594
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of the carbohydrate antigen CA-50 in pancreatic disease.
Blind PJ; Dahlgren ST
Acta Chir Scand; 1987 Jan; 153(1):45-9. PubMed ID: 3472420
[TBL] [Abstract][Full Text] [Related]
13. Serum CA 19-9 concentrations and computed tomography findings in patients with pancreatic carcinoma.
Sakahara H; Endo K; Nakajima K; Nakashima T; Koizumi M; Ohta H; Hidaka A; Kohno S; Nakano Y; Naito A
Cancer; 1986 Apr; 57(7):1324-6. PubMed ID: 3456252
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of carbohydrate antigens 19-9 and 12-5 in patients with pancreatic cancer.
Pasquali C; Sperti C; D'Andrea AA; Bonadimani B; Del Favero G; Petrin P; Pedrazzoli S
Pancreas; 1987; 2(1):34-7. PubMed ID: 3472197
[TBL] [Abstract][Full Text] [Related]
15. CA 19-9 in serum and pancreatic juice: its role in the differential diagnosis of resectable pancreatic cancer from chronic pancreatitis.
Malesci A; Evangelista A; Mariani A; Bersani M; Bonato C; Basilico M; Montorsi M; Beretta E
Int J Pancreatol; 1988; 3 Suppl 1():S119-23. PubMed ID: 3209865
[TBL] [Abstract][Full Text] [Related]
16. [Importance of the tumor-associated antigen CA 19-9 in the differential diagnosis of pancreatic diseases].
Heptner G; Domschke S; Schneider MU; Domschke W
Dtsch Med Wochenschr; 1985 Apr; 110(16):624-8. PubMed ID: 3857159
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic importance of the tumor marker CA 19-9 in pancreatic cancer].
Safi F; Büchler M; Schenkluhn B; Beger HG
Dtsch Med Wochenschr; 1984 Dec; 109(49):1869-73. PubMed ID: 6209082
[TBL] [Abstract][Full Text] [Related]
18. DU-PAN-2 levels in serum and pancreatic ductal fluids of patients with benign and malignant pancreatic disease.
Mahvi DM; Seigler HF; Meyers WC; Kalthoff H; Schmiegel WH; Metzgar RS
Pancreas; 1988; 3(4):488-93. PubMed ID: 3174610
[TBL] [Abstract][Full Text] [Related]
19. CA 19-9 in the differential diagnosis between pancreatic cancer and chronic pancreatitis.
Farini R; Fabris C; Bonvicini P; Piccoli A; del Favero G; Venturini R; Panucci A; Naccarato R
Eur J Cancer Clin Oncol; 1985 Apr; 21(4):429-32. PubMed ID: 3859414
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous fine-needle aspiration cytologic study of main pancreatic duct stenosis under pancreatographic guidance.
Gagnon P; Boustiere C; Ponchon T; Valette PJ; Genin G; Labadie M
Cancer; 1991 May; 67(9):2395-400. PubMed ID: 2013042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
